Wingate HF - Search Results

1

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer.

Hunt KK, Suman VJ, Wingate HF, Leitch AM, Unzeitig G, Boughey JC, Meric-Bernstam F, Ellis MJ, Olson J. Hunt KK, et al. Among authors: wingate hf. Ann Surg Oncol. 2023 Apr;30(4):2111-2118. doi: 10.1245/s10434-022-12972-5. Epub 2023 Jan 18. Ann Surg Oncol. 2023. PMID: 36653664 Free PMC article. Clinical Trial.

2

Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.

Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K, Keyomarsi K. Wingate H, et al. Cell Cycle. 2009 Apr 1;8(7):1062-8. doi: 10.4161/cc.8.7.8119. Epub 2009 Apr 10. Cell Cycle. 2009. PMID: 19305161 Free PMC article.

3

Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.

Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi K. Akli S, et al. Clin Cancer Res. 2010 Feb 15;16(4):1179-90. doi: 10.1158/1078-0432.CCR-09-1787. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145171 Free PMC article.

4

Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells.

Sun B, Wingate H, Swisher SG, Keyomarsi K, Hunt KK. Sun B, et al. Cell Cycle. 2010 Mar 15;9(6):1122-30. doi: 10.4161/cc.9.6.10990. Epub 2010 Mar 15. Cell Cycle. 2010. PMID: 20237430

5

MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells.

Valero V 3rd, Wingate H, Chada S, Liu Y, Palalon F, Mills G, Keyomarsi K, Hunt KK. Valero V 3rd, et al. Cancer Gene Ther. 2011 Jul;18(7):510-9. doi: 10.1038/cgt.2011.20. Epub 2011 May 6. Cancer Gene Ther. 2011. PMID: 21546925 Free PMC article.

6

Targeting low molecular weight cyclin E (LMW-E) in breast cancer.

Nanos-Webb A, Jabbour NA, Multani AS, Wingate H, Oumata N, Galons H, Joseph B, Meijer L, Hunt KK, Keyomarsi K. Nanos-Webb A, et al. Breast Cancer Res Treat. 2012 Apr;132(2):575-88. doi: 10.1007/s10549-011-1638-4. Epub 2011 Jun 22. Breast Cancer Res Treat. 2012. PMID: 21695458 Free PMC article.

7

LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.

Duong MT, Akli S, Wei C, Wingate HF, Liu W, Lu Y, Yi M, Mills GB, Hunt KK, Keyomarsi K. Duong MT, et al. Among authors: wingate hf. PLoS Genet. 2012;8(3):e1002538. doi: 10.1371/journal.pgen.1002538. Epub 2012 Mar 29. PLoS Genet. 2012. PMID: 22479189 Free PMC article.

8

Satisfaction and Sustainability in a Surgical Career.

Hunt KK, Wingate HF. Hunt KK, et al. Among authors: wingate hf. Ann Surg Oncol. 2018 Oct;25(10):2785-2789. doi: 10.1245/s10434-018-6577-4. Epub 2018 Jul 10. Ann Surg Oncol. 2018. PMID: 29992496 Free PMC article. No abstract available.

9

Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer.

Karakas C, Francis AM, Ha MJ, Wingate HF, Meena RA, Yi M, Rasaputra KS, Barrera AMG, Arun B, Do KA, Sahin A, Keyomarsi K, Hunt KK. Karakas C, et al. Among authors: wingate hf. Ann Surg. 2021 Aug 1;274(2):e150-e159. doi: 10.1097/SLA.0000000000003551. Ann Surg. 2021. PMID: 31436549 Free PMC article.

10

[No title available]

[No authors listed] [No authors listed] PMID: 36745260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page